1 Meditrust Exhibit 11 Statement Regarding Computation of Earnings Per Share (In thousands except per Share amounts) Year ended December 31, ------------------------------------------ Primary 1993 1992 1991 ======= ---- ----- ----- Weighted average shares 31,310 26,360 21,710 Dilutive effect of: Stock options 119 173 83 Warrants 62 99 165 ------- ------- -------- Weighted average number of shares and equivalent shares outstanding 31,491 26,632 21,958 ======= ======= ======== Net income before extraordinary item $63,636 $51,358 $37,909 Loss on prepayment of debt (3,684) ------- ------- ------- Net income $63,636 $51,358 $34,225 ======= ======= ======= Per Share amounts: Net income before extraordinary item $2.02 $1.93 $1.73 Loss on prepayment of debt (0.17) ----- ------ ------ Net income (A) $2.02 $1.93 $1.56 ===== ===== ===== (A) This calculation is submitted in accordance with Regulation S-K item 601 (b) (11) although not required by footnote 2 to paragraph 14 of APB Opinion No. 15 because it results in dilution of less than 3%. Fully Diluted ============= Weighted average number of shares used in primary calculation 31,491 26,632 21,958 Assumed conversion of convertible debentures 5,246 2,491 ------- ------- ------ Fully diluted weighted average shares and equivalent shares outstanding 36,737 29,123 21,958 ======= ======= ======= Net income before extraordinary item $63,636 $51,358 $37,909 Interest and debt issuance costs on convertible debentures 12,352 6,277 ------- ------- ------- Adjusted net income for fully diluted calculation 75,988 57,635 37,909 Loss on prepayment of debt (3,684) ------- ------- ------- Net income $75,988 $57,635 $34,225 ======= ======= ======= Per Share amounts: Net income before extraordinary item $2.07 $1.98 $1.73 Loss on prepayment of debt (0.17) ----- ----- ----- Net income (B) $2.07 $1.98 $1.56 ===== ===== ===== (B) This calculation is submitted in accordance with Regulation S-K item 601(b) (11) although it is contrary to paragraph 40 of APB Opinion No. 15 because it produces an anti-dilutive result.